Osaic Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549 | Sell |
742
-200
| -21% | -$148 | ﹤0.01% | 6823 |
|
|
2025
Q1 | $433 | Buy |
942
+200
| +27% | +$92 | ﹤0.01% | 6857 |
|
|
2024
Q4 | $549 | Hold |
742
| – | – | ﹤0.01% | 6833 |
|
|
2024
Q3 | $1.16K | Hold |
742
| – | – | ﹤0.01% | 6608 |
|
|
2024
Q2 | $1.25K | Sell |
742
-693
| -48% | -$1.16K | ﹤0.01% | 6570 |
|
|
2024
Q1 | $3.44K | Buy |
1,435
+41
| +3% | +$98 | ﹤0.01% | 6121 |
|
|
2023
Q4 | $2.13K | Sell |
1,394
-5,850
| -81% | -$8.95K | ﹤0.01% | 6396 |
|
|
2023
Q3 | $7.9K | Buy |
7,244
+876
| +14% | +$955 | ﹤0.01% | 6016 |
|
|
2023
Q2 | $14.6K | Buy |
6,368
+3,486
| +121% | +$7.98K | ﹤0.01% | 5726 |
|
|
2023
Q1 | $7K | Sell |
2,882
-392
| -12% | -$952 | ﹤0.01% | 6128 |
|
|
2022
Q4 | $6K | Sell |
3,274
-340
| -9% | -$623 | ﹤0.01% | 6174 |
|
|
2022
Q3 | $8K | Buy |
3,614
+1,023
| +39% | +$2.27K | ﹤0.01% | 6100 |
|
|
2022
Q2 | $4K | Buy |
2,591
+109
| +4% | +$168 | ﹤0.01% | 6560 |
|
|
2022
Q1 | $4K | Sell |
2,482
-77
| -3% | -$124 | ﹤0.01% | 6519 |
|
|
2021
Q4 | $10K | Buy |
2,559
+1,035
| +68% | +$4.05K | ﹤0.01% | 6189 |
|
|
2021
Q3 | $7K | Buy |
1,524
+200
| +15% | +$919 | ﹤0.01% | 6364 |
|
|
2021
Q2 | $6K | Sell |
1,324
-365
| -22% | -$1.65K | ﹤0.01% | 6261 |
|
|
2021
Q1 | $10K | Sell |
1,689
-101
| -6% | -$598 | ﹤0.01% | 5835 |
|
|
2020
Q4 | $5K | Buy |
1,790
+646
| +56% | +$1.8K | ﹤0.01% | 5713 |
|
|
2020
Q3 | $1K | Sell |
1,144
-1,476
| -56% | -$1.29K | ﹤0.01% | 5946 |
|
|
2020
Q2 | $5K | Buy |
2,620
+375
| +17% | +$716 | ﹤0.01% | 5422 |
|
|
2020
Q1 | $4K | Buy |
+2,245
| New | +$4K | ﹤0.01% | 5375 |
|